HOME >> BIOLOGY >> NEWS
Sightless cavefish may offer clues to eye growth, Science authors report

nto the cavefish eye, and watch to see if it stimulates eye growth."

As embryos, cavefish such as Astyanax mexicanus, collected in caves beneath northeastern Mexico, begin to form eyes. But, the young lens soon degenerates, so that the cornea, iris, pupil, and other optic tissues that depend on signals from the lens are absent or rudimentary, the Science paper notes. In adult cavefish, all that remains is a collapsed remnant of the eye, covered by a flap of skin.

To learn whether the lens plays a role in triggering eye growth, the research team compared the sightless cavefish with closely related, sighted fish of the same species, gathered from surface streams outside the caves. The lens precursor tissue from embryos of the surface-dwelling fish was surgically implanted into the eye cup of the developing cavefish, after its own degenerating lens tissue was removed. By implanting the lens only into one eye of each cavefish, researchers were able to compare the eye-forming capacity of the transplanted lens with the degenerating lens in the same animal.

Within eight days, Jeffery and Yamamoto began to see a larger eye on the transplanted side of the cavefish. After two months, cavefish had grown a large eye with a distinct pupil, cornea, and iris. In addition, the retina of the eye with the implanted lens showed rod photoreceptor cells, which are absent or rare in the degenerate cavefish eye. This shows that "the lens is able to stimulate the development of eye parts that have been lost during the past million or so years of cavefish evolution," Jeffery says.

When the experiment was reversed, so that surface-dwelling fish received the lens from a cavefish, the transplant failed to support eye growth. The researchers concluded, therefore, that "a change in lens signaling to other parts of the eye is a major cause of eye degeneration in cavefish." They caution, however, that other factors also may contribute to eye loss, and further
'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
26-Jul-2000


Page: 1 2 3

Related biology news :

1. Lake research offers clues to managing crayfish invasions
2. Comparing primate genomes offers insight into human evolution
3. UW study: Migrating birds offer insight into sleep
4. Only 21 states offer newborn screening tests recommended by March of Dimes
5. Study of proteins offers insights into organization of biological networks
6. Susceptibility of mice to mousepox offers promise of smallpox protection
7. Discovery in parasite movement may offer insights into malaria
8. Botulinum toxin structure offers clues for vaccines/treatments
9. Discovery offers clues to origin of life
10. Guiding gas exploration: U-M research offers inexpensive tool
11. A multi-institutional study may offer clues for the treatment of some autoimmune diseases

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sightless cavefish may offer clues eye growth authors report

(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... AUSTIN, Texas , Dec. 16, 2014  Vermillion, ... company focused on gynecologic disease, today announced the next ... into a premier bio-analytics solutions provider with the naming ... to President and Chief Executive Officer, while current Chairman ... will continue to serve as Chairman. These changes are ...
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
Cached News: